13D Filing: Birchview Capital and Yield10 Bioscience Inc. (YTEN)

As of the date
hereof, Mr. Strobeck is deemed to beneficially own 352,713 shares of Common Stock, representing approximately 4.1% of the
shares of the Common Stock of the Issuer outstanding, which includes the Fund Shares and 166,634 shares of Common Stock beneficially
owned by Mr. Strobeck.

The Fund:

(i)

Sole power to vote or to direct the vote: 186,079

(ii)

Shared power to vote or direct the vote: 0

(iii)

Sole power to dispose or to direct the disposition of: 186,079

(iv)

Shared power to dispose of to direct the disposition of: 0

The Investment Manager:

(i)

Sole power to vote or to direct the vote: 350,536

(ii)

Shared power to vote or direct the vote: 0

(iii)

Sole power to dispose or to direct the disposition of: 350,536

(iv)

Shared power to dispose of to direct the disposition of: 0

The GP:

(i)

Sole power to vote or to direct the vote: 350,536

(ii)

Shared power to vote or direct the vote: 0

(iii)

Sole power to dispose or to direct the disposition of: 350,536

(iv)

Shared power to dispose of to direct the disposition of: 0

The Manager:

(i)

Sole power to vote or to direct the vote: 350,536